A case of merkel leptomeningeal evolution after complete remission upon anti-PD-1 treatment

Eur J Cancer. 2019 May:113:55-57. doi: 10.1016/j.ejca.2019.03.009. Epub 2019 Apr 11.

Affiliations

¹ Department of Dermatology, Paul Sabatier - Toulouse III University, IUC and CHU de Toulouse, Toulouse, France.
² Department of Neuro-oncology, Paul Sabatier - Toulouse III University, IUC and CHU de Toulouse, Toulouse, France.
³ Department of Pathology, Paul Sabatier - Toulouse III University, IUC and CHU de Toulouse, Toulouse, France.
⁴ Department of Dermatology, Paul Sabatier - Toulouse III University, IUC and CHU de Toulouse, Toulouse, France. Electronic address: meyer.n@chu-toulouse.fr.

PMID: 30981092
DOI: 10.1016/j.ejca.2019.03.009

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents, Immunological / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carboplatin / administration & dosage
Carcinoma, Merkel Cell / secondary
Carcinoma, Merkel Cell / therapy*
Etoposide / administration & dosage
Humans
Lower Extremity
Magnetic Resonance Imaging
Male
Meningeal Carcinomatosis / drug therapy*
Meningeal Carcinomatosis / secondary
Nivolumab / therapeutic use*
Peritoneal Neoplasms / drug therapy*
Peritoneal Neoplasms / secondary
Radiotherapy, Adjuvant
Remission Induction
Skin Neoplasms / pathology
Skin Neoplasms / therapy*

Substances

Antineoplastic Agents, Immunological
Nivolumab
Etoposide
Carboplatin